Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Suspended 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 1Lymphoid 1

Conditions

Breast Neoplasms 8Prostatic Neoplasms 7Colorectal Neoplasms 4Colorectal Neoplasms, Hereditary Nonpolyposis 3Rectal Neoplasms 2Ovarian Neoplasms 2Neoplastic Syndromes, Hereditary 2Colonic Neoplasms 2Carcinoma, Intraductal, Noninfiltrating 2Tuberous Sclerosis 1Thyroid Neoplasms 1Sarcoma 1Pyloric Stenosis, Hypertrophic 1Primary Ovarian Insufficiency 1Polycystic Ovary Syndrome 1Pheochromocytoma 1Pediatric Solid Tumor 1Paraganglioma 1Pancreatic Neoplasms 1Pancreatic Ductal Adenocarcinoma 1Neoplasms, Unknown Primary 1Neoplasms 1Neoplasm Metastasis 1Multiple Myeloma 1Melanoma 1Lymphoproliferative Disorders 1Lymphangioleiomyomatosis 1Lipodystrophy, Familial Partial 1Kidney Neoplasms 1Histiocytosis, Non-Langerhans-Cell 1

Interventions

temsirolimus 1Valproic Acid 1Sirolimus 1Immunoglobulin G 1Genetic Testing 1Disulfides 1Cetuximab 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Castleman Disease × Genetic Testing × 1 year × Clear all
NCT05028621 2026-05-07

Molecular Basis of Langerhans and Non-Langerhans Cell Histiocytic Neoplasms and Castleman Disease

Case Comprehensive Cancer Center

Phase NA Suspended
135 enrolled
LymphoidMyeloid

Castleman Disease, Histiocytosis, Langerhans-Cell, Histiocytosis, Non-Langerhans-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡